Applying UHPLC HRAM MS-MS/MS method to assess host cell protein clearance during the purification process development of therapeutic mAbs

Posters | 2024 | Thermo Fisher Scientific | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/HRMS, LC/Orbitrap
Industries
Pharma & Biopharma, Proteomics
Manufacturer
Thermo Fisher Scientific
Downloadable PDF for viewing
 

Similar PDF

LC-MS-based host cell protein (HCP) identification and monitoring during biopharmaceutical downstream process development
High-sensitivity Host Cell Protein (HCP) analysis on a new Orbitrap Excedion Pro BioPharma hybrid mass spectrometer with optimized sample preparation
Rapid monitoring of mAb aggregates during the purification process development of therapeutic mAbs using a modified Orbitrap hybrid MS
Residual host cell protein analysis of NISTmAb: From simplified sample preparation to reliable results